GlassScriptPhysician profile
Usama Bukhari
NPI 1568818128
$897.23
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.95 · 2020: $125 · 2021: $234 · 2022: $140 · 2023: $186 · 2024: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $151.79 | 2020-2023 | |
| Vifor Pharma, INC. | $150.20 | 2019-2023 | Veltassa |
| Janssen Pharmaceuticals, INC | $110.65 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $109.33 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.14 | 2023-2024 | Xifaxan |
| Gilead Sciences, INC. | $45.53 | 2022-2024 | Veklury |
| Ceribell, INC. | $40.83 | 2024 | Pocket Eeg Device |
| Mylan Specialty L.P. | $40.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.20 | 2020-2021 | |
| Abbvie INC. | $24.23 | 2021 | |
| Allergan, INC. | $24.00 | 2020 | |
| Abbott Laboratories | $23.08 | 2023 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.72 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $19.67 | 2023 | Andexxa |
| Ferring Pharmaceuticals INC. | $19.49 | 2023 | Rebyota |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.20 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usama Bukhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.